A Markov model was used to simulate the effects of standard prevention compared to tibial neurolysis on the long-term costs associated with foot ulcers and amputations. This model included eight health states. A baseline analysis was built on a five-year model to determine the cumulative incidence of foot ulcers and amputations with each strategy. Subsequently, a cost-effectiveness analysis and cohort-level Markov simulations were conducted with a model composed of 20 six-month cycles. The outcomes explored were quality adjusted life years (QALYs); the incremental cost-effectiveness of tibial neurolysis in comparison with standard treatment and the net monetary benefits of tibial neurolysis. A sensitivity analysis was also performed.
CONCLUSION:
These results suggest that among patients with diabetic neuropathy and superimposed nerve compression, surgery is more effective at preventing serious comorbidities and is associated with a higher survival over time. While more costly initially, surgery is more cost-effective than the current prevention strategy. It also generated greater long-term economic benefits than those obtained with standard prevention. These results coupled with the QALYs gained make surgery the strategy worth considering.
Trends observed over a 10-year simulation period (20 sixmonth stages) showing a considerably higher probability of preventing foot ulcers in the surgical intervention strategy. Amputations and mortality are also lower in this group. There are multiple post-operative protocols in the literature for autologous free flap breast reconstruction patients. Commonly, this demographic of patients can be admitted to the intensive care unit (ICU) postoperatively for close monitoring of flap viability and then be subsequently transferred to a general surgical floor prior to discharge. With the advent of devices that enable continuous tissue-oximetry monitoring, it may no longer be necessary for these patients to go to the ICU post-operatively. We aim to show that our three-day post-operative protocol not only maintains excellent clinical outcomes, but is also more cost and resource effective than protocols with longer length of stay (LOS) or overutilization of the ICU.
METHODS:
Current literature was reviewed for validation of tissue oximetry use in free flap monitoring. Costs for our post-operative pathway were collected from the Department of Plastic and Reconstructive Surgery. We abstracted demographics, LOS and short-term complications on all consecutive patients who underwent autologous free flap breast reconstruction at our institution from January 2013 to August 2014. Our complication rates were then compared to those in the literature.
RESULTS:
We reviewed 153 consecutive patients with a total of 239 free flaps using our post-operative protocol. The mean age was 50 years (SD=10.2) and mean body mass index (BMI) was 29.4 (SD=5.2). Our institution's rate of flap failure was not significantly different from the published national rate (p=0.367). Unplanned reoperation was significantly lower than the published national rate (p<0.001). Patients are cared for immediately on the general surgical floor, which costs $1827/day compared to the national average for monitoring a non-mechanically ventilated patient in the ICU of $6667/day. We use one tissue oximetry probe per free flap, which cost $713 each. 71% of patients are discharged on or before POD 3. Patients who are discharged after POD 5 were due to complications, including pulmonary embolism, infection and deep vein thrombosis. Our protocol has been standard of care for over 12
